Brief: Bellicum announces appointment of Rick Fair as CEO
31/01/2017 12:00
Jan 31 (Reuters) - Bellicum Pharmaceuticals Inc BLCM.O :
* Bellicum announces appointment of Rick Fair as chief
executive officer in preparation for commercialization of
bpx-501 and next phase of growth
* Bellicum pharmaceuticals - fair joins Bellicum from
Genentech/Roche, where he was senior vice president, head of
oncology global product strategy
* Bellicum Pharmaceuticals Inc - Fair succeeds Tom Farrell,
who will serve as an advisor to company during transition
Source text for Eikon: ID:nGNXNPWUEa
Further company coverage: BLCM.O
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Bellicum Pharmaceuticals
See all newsBrief: Bellicum Pharmaceuticals- In Connection With Dissolution And Plan Of Dissolution, On February 23, Richard A. Fair Resigned As President And Co's CEO
Brief: Bellicum Pharmaceuticals Says Board Approved Liquidation And Dissolution Of Co In Connection With Approval Of Asset Purchase Agreement
Brief: Bellicum Pharmaceuticals Initiated A 12 Stock Split On Dec 8, 2022
Brief: Bellicum Reports Third Quarter 2022 Financial Results And Provides Operational Update
Bellicum Pharmaceuticals Inc expected to post a loss of 64 cents a share - Earnings Preview